|
?:authorAffiliation
|
-
[\'Division of Medical Toxicology, Department of Emergency Medicine, Brigham and Women\'s Hospital, Boston, MA, 02115, USA. pchai@bwh.harvard.edu.\', \'Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, Boston, MA, USA. pchai@bwh.harvard.edu.\', \'The Fenway Institute, Boston, MA, USA. pchai@bwh.harvard.edu.\', \'The Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology, Boston, MA, USA. pchai@bwh.harvard.edu.\', \'Department of Medicine, Brigham and Women\'s Hospital, Boston, MA, USA.\', \'Department of Emergency Medicine, Harvard Medical School, Boston, MA, USA.\', \'Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.\', \'Division of Medical Toxicology, Department of Emergency Medicine, Brigham and Women\'s Hospital, Boston, MA, 02115, USA.\', \'Department of Pharmacy, Brigham and Women\'s Hospital, Boston, MA, USA.\', \'The Fenway Institute, Boston, MA, USA.\', \'Harvard Humanitarian Institute, Boston, MA, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}